Duality Biotherapeutics, Inc. (HKG:9606)
172.20
-11.70 (-6.36%)
Sep 10, 2026, 1:14 PM HKT
Duality Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $250.47 | Buy | Maintains | $250.47 | +45.45% | Sep 4, 2026 |
Unknown Analyst Essence Securities No rating | Essence Securities | Buy Maintains $250.47 | Buy | Maintains | $250.47 | +45.45% | Sep 4, 2026 |
Unknown Analyst Huachuang Securities No rating | Huachuang Securities | Buy Maintains $287.40 | Buy | Maintains | $287.40 | +66.90% | Sep 4, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $284.50 | Buy | Maintains | $284.50 | +65.21% | Sep 2, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $320.00 | Buy | Maintains | $320.00 | +85.83% | Aug 13, 2026 |
Unknown Analyst Soochow Securities No rating | Soochow Securities | Buy Maintains $418.61 | Buy | Maintains | $418.61 | +143.10% | Jul 8, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $520.49 | Buy | Maintains | $520.49 | +202.26% | Apr 10, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $457.74 | Buy | Maintains | $457.74 | +165.82% | Apr 9, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.